{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["biliary cirrhosis", "bilirubin", "chronotropic", "dromotropic", "rat", "vanillic acid"]], "OtherID": [], "CitationSubset": [], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27382452", "DateCompleted": {"Year": "2016", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "05", "Day": "25"}], "ELocationID": ["10.19082/2410"], "Language": ["eng"], "Journal": {"ISSN": "2008-5842", "JournalIssue": {"Volume": "8", "Issue": "5", "PubDate": {"Year": "2016", "Month": "May"}}, "Title": "Electronic physician", "ISOAbbreviation": "Electron Physician"}, "ArticleTitle": "Ameliorative Effect of Vanillic Acid on Serum Bilirubin, Chronotropic and Dromotropic Properties in the Cholestasis-Induced Model Rats.", "Pagination": {"StartPage": "2410", "EndPage": "2415", "MedlinePgn": "2410-5"}, "Abstract": {"AbstractText": ["The liver modulates several important roles, such as metabolism and liver cirrhosis, which have several cardiovascular problems. Due to preservative role of antioxidant agents in cardiovascular disease, consequently, many of them are applied as medicinal plants in traditional medicine. Vanillic acid (VA), as an antioxidant agent, has a principal preservative role on some diseases. In this study, the effect of vanillic acid was examined on heart rate (as chronotropic property), P-R interval (as dromotropic property), and serum bilirubin in cholestasis-induced model rats.", "In this study, 32 male Sprague-Dawley rats weighing 200-250 g were allocated into four groups, and each group contained eight rats as follows: Control (normal saline, 1 ml/kg, gavage, daily for 4 weeks), cirrhotic (normal saline, 1 ml/kg, gavage, daily for 4 weeks), vanillic acid (10 mg/kg, gavage, daily for 4 weeks), cirrhotic treated with vanillic acid (10 mg/kg, gavage, daily for 4 weeks). Chronic biliary cirrhosis was induced in cirrhotic groups by four weeks Bile Duct Ligation (BDL). At the first day and four weeks after surgery, the animals were anesthetized, electrocardiograms were recorded (lead II), and chronotropic and dromotropic properties (HR and PR interval) were investigated. At the end of experimental duration, the animals were anesthetized, and blood samples were taken to measure serum bilirubin. The results were analyzed using t-test and one-way ANOVA by SPSS software, version 22.", "After induced of BDL, the results presented that laboratory parameter (bilirubin) in the cirrhotic group significantly increased compared to the control group. The P-R interval was reduced in the cirrhotic group compared to the control group, and there was no significant difference between heart rate in all groups. Bilirubin were reduced in cirrhotic groups treated with vanillic acid (VA) compared to cirrhotic group and also administration of VA in the cirrhotic treated with VA increased dromotropic property in comparison with the cirrhotic group.", "According to the results obtained in this study, preventing elevated bilirubin and increase dromotropic property in cirrhotic group taking the VA suggested that the consumption of vanillic acid as an antioxidant can be effective in the prevention of liver diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "M.Sc. of Physiology, Department of Physiology and Physiology Research Center, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Atefipour", "ForeName": "Narges", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ph.D. of Physiology, Faculty Member, Physiology Research Center and Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Dianat", "ForeName": "Mahin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ph.D. of Physiology, Faculty Member, Physiology Research Center and Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Badavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ph.D. of Physiology, Faculty Member, Physiology Research Center and Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Sarkaki", "ForeName": "Alireza", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Electron Physician", "NlmUniqueID": "101645099", "ISSNLinking": "2008-5842"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Giannelli G, Quaranta V, Antonaci S. Tissue remodelling in liver diseases. Histol Histopathol. 2003;18:1267\u201374.", "ArticleIdList": ["12973693"]}, {"Citation": "Al-Attar AM, Shawush NA. Influence of olive and rosemary leaves extracts on chemically induced liver cirrhosis in male rats. Saudi J Biol Sci. 2015;22(2):157\u201363. doi: 10.1016/j.sjbs.2014.08.005.", "ArticleIdList": ["10.1016/j.sjbs.2014.08.005", "PMC4336450", "25737646"]}, {"Citation": "Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrisons Principles of Internal Medicine. 17th Edition. McGraw-Hill; New York: 2008. pp. 12\u20134."}, {"Citation": "Hirschfield GM, Mason A, Luketic V, Lindor K, Gordon SC, Mayo M, et al. Efficacy of Obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology. 2015;148(4):751\u201361.e8. doi: 10.1053/j.gastro.2014.12.005.", "ArticleIdList": ["10.1053/j.gastro.2014.12.005", "25500425"]}, {"Citation": "Lotkova H, Stankova P, Rousar T, Ku\u010dera O, Kohoutek L, Mi\u010duda S, et al. Deteriorating effect of fluvastatin on the cholestatic liver injury indused by bile duct ligation in rats. Gen Physiol Biophys. 2011;30:66\u201374. doi: 10.4149/gpb_2011_01_66.", "ArticleIdList": ["10.4149/gpb_2011_01_66", "21460414"]}, {"Citation": "Scartezzini P, Speroni E. Riview on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000;71(1):23\u201343. doi: 10.1016/S0378-8741(00)00213-0.", "ArticleIdList": ["10.1016/S0378-8741(00)00213-0", "10904144"]}, {"Citation": "Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, et al. Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci. 2005;25(1):57\u201365. doi: 10.1016/j.ejps.2005.01.015.", "ArticleIdList": ["10.1016/j.ejps.2005.01.015", "15854801"]}, {"Citation": "Chou TH, Ding HY, Hung WJ, Liang CH. Antioxidative characteristics and inhibition of alpha-melanocyte-stimulating hormone-stimulated melanogenesis of vanillin and vanillic acid from Origanum vulgare. Exp Dermatol. 2010;19(8):742\u201350. doi: 10.1111/j.1600-0625.2010.01091.x.", "ArticleIdList": ["10.1111/j.1600-0625.2010.01091.x", "20482617"]}, {"Citation": "Lirdprapamongkol K, Kramb JP, Suthiphongchai T, Surarit R, Srisomsap C, Dannhardt G, et al. Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. J Agric Food Chem. 2009;57(8):3055\u201363. doi: 10.1021/jf803366f.", "ArticleIdList": ["10.1021/jf803366f", "19368348"]}, {"Citation": "Strand LP, Scheline RR. The metabolism of vanillin and isovanillin in the rat. Xenobiotica. 1975;5:49\u201363. doi: 10.3109/00498257509056093.", "ArticleIdList": ["10.3109/00498257509056093", "1154798"]}, {"Citation": "Muskiet FAJ, Groen A. Urinary excretion of conjugated homo-vanillic acid, 3,4dihydroxyphenylacetic acid, p-hydroxyphenylacetic acid and vanillic acid by persons on their usual diet and patients with neuroblastoma. Clin Chem. 1979;25:1281\u20134.", "ArticleIdList": ["455649"]}, {"Citation": "Odink J, Korthals H, Knijff JH. Simultaneous determination of the major acidic metabolites of catecholamines and serotonin in urine by liquid chromatography with electrochemical detection after a one-step sample clean-up on sephadex G-10; influence of vanilla and banana ingestion. J Chromatogr. 1988;424:273\u201383. doi: 10.1016/S0378-4347(00)81104-4.", "ArticleIdList": ["10.1016/S0378-4347(00)81104-4", "2453525"]}, {"Citation": "Ozeir M, Muhlenhoff U, Webert H, Lill R, Fontecave M, Pierrel F. Coenzyme Q biosynthesis: Coq6 is required for the C5-hydroxylation reaction and substrate analogs rescue Coq6 deficiency. Chem Biol. 2011;18:1134\u201342. doi: 10.1016/j.chembiol.2011.07.008.", "ArticleIdList": ["10.1016/j.chembiol.2011.07.008", "21944752"]}, {"Citation": "Kim SJ, Kim MC, Um JY, Hong SH. Anti-Inflammatory activity of chrysophanol through the suppression of NF-kappaB/caspase-1 activation in vitro and in vivo. Molecules. 2010;15(9):7208\u201317. doi: 10.3390/molecules15107208.", "ArticleIdList": ["10.3390/molecules15107208", "PMC6257778", "20877234"]}, {"Citation": "Batish DR, Lavanya K, Singh HP, Kohli RK. Root-mediated Allelopathic interference of Nettle-leaved Goosefoot (Chenopodium murale) on wheat (Triticum aestivum) J of Agronomy and Crop Science. 2007;193(1):37\u201344. doi: 10.1111/j.1439-037X.2006.00243.x.", "ArticleIdList": ["10.1111/j.1439-037X.2006.00243.x"]}, {"Citation": "Mac\u00ecas FA, Simonet AM, Galindo JCG, Castellano D. Bioactive phenolics and polar compounds from Melilotus messanensis. Phytochemistry. 1999;50:35\u201346."}, {"Citation": "Zhang Z, Liao L, Moore J, Wu T, Wang Z. Antioxidant phenolic compounds from walnut kernels (Juglans regia L.) Food Chem. 2008;113:160\u20135. doi: 10.1016/j.foodchem.2008.07.061.", "ArticleIdList": ["10.1016/j.foodchem.2008.07.061"]}, {"Citation": "Parveen I, Winters A, Threadgill MD, Hauck B, Morris P. Extraction, structural characterization and evaluation of hydroxycinna of orchard grass (Dactylis glomerata) as substrates for polyphenol oxide. Phytochemistry. 2008;69:2799\u2013806. doi: 10.1016/j.phytochem.2008.08.019.", "ArticleIdList": ["10.1016/j.phytochem.2008.08.019", "18929376"]}, {"Citation": "Tai A, Sawano T, Ito H. Antioxidative properties of vanillic acid esters in multiple antioxidant assays. Biosci Biotechnol Biochem. 2012;76(2):314\u20138. doi: 10.1271/bbb.110700.", "ArticleIdList": ["10.1271/bbb.110700", "22313772"]}, {"Citation": "Prince PSM, Dhanasekar K, Rajakumar S. Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study. Cardiovas Toxicol. 2011;11(1):58\u201366. doi: 10.1007/s12012-010-9098-3.", "ArticleIdList": ["10.1007/s12012-010-9098-3", "21161433"]}, {"Citation": "Prince PSM, Rajakumar S, Dhanasekar K. Protective effects of vanillic acid on electrocardiogram, Lipid peroxidation, antioxidants, proinflammatory markers and histopathology in isoprotenol induced cardiotoxic rats. Eur J Pharmacol. 2011;668(1\u20132):233\u201340. doi: 10.1016/j.ejphar.2011.06.053.", "ArticleIdList": ["10.1016/j.ejphar.2011.06.053", "21763302"]}, {"Citation": "Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998;274( 3Pt 2):H747\u201351.", "ArticleIdList": ["9530184"]}, {"Citation": "Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest. 2003;112(11):1678\u201387. doi: 10.1172/JCI18945.", "ArticleIdList": ["10.1172/JCI18945", "PMC281645", "14623915"]}, {"Citation": "Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21(1):40\u2013125. doi: 10.1016/j.bpg.2006.06.003.", "ArticleIdList": ["10.1016/j.bpg.2006.06.003", "17223501"]}, {"Citation": "Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, Ucar M, et al. Protective effects of caffeic acid phenethyl ester on doxorubicin-indused cardiotoxicity in rats. J Appl Toxicol. 2004;24(1):47\u201352. doi: 10.1002/jat.945.", "ArticleIdList": ["10.1002/jat.945", "14745846"]}, {"Citation": "Ebrahimkhani MR, Moezi L, Kiani S, Merat S, Dehpour AR. Opioid receptor blockade improves mesentric responsiveness in billiary cirrhosis. Dig Dis Sci. 2008;53(11):3007\u201311. doi: 10.1007/s10620-008-0261-7.", "ArticleIdList": ["10.1007/s10620-008-0261-7", "18465246"]}, {"Citation": "Somova LI. Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Phytomedicine. 2004;11(2\u20133):121\u20139. doi: 10.1078/0944-7113-00329.", "ArticleIdList": ["10.1078/0944-7113-00329", "15070161"]}, {"Citation": "Fern\u00e1ndez-Mart\u00ecnez E, Perez-Alvarez V, Tsutsumi V, Shibayama M, Muriel P. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. Exp Toxicol Pathol. 2006;58(1):49\u201358. doi: 10.1016/j.etp.2006.03.002.", "ArticleIdList": ["10.1016/j.etp.2006.03.002", "16617007"]}, {"Citation": "Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest. 2003;112(11):1678\u201387. doi: 10.1172/JCI200318945.", "ArticleIdList": ["10.1172/JCI200318945", "PMC281645", "14623915"]}, {"Citation": "Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44(5):994\u20131002. doi: 10.1016/j.jhep.2005.10.034.", "ArticleIdList": ["10.1016/j.jhep.2005.10.034", "16510203"]}, {"Citation": "Manthey JA, Perkins-Veazie P. Influences of harvest date and location on the levels of \u03b2-carotene, ascorbic acid, total phenols, the in vitro antioxidant capacity, and phenolic profiles of five commercial varieties of mango (Mangifera indica L.) J Agric Food Chem. 2009;57(22):10825\u201330. doi: 10.1021/jf902606h.", "ArticleIdList": ["10.1021/jf902606h", "19919121"]}, {"Citation": "Kaese S, Verheule S. Cardiac electrophysiology in mice: a matter of size. Front Physiol. 2012;345(3):198\u2013205. doi: 10.3389/fphys.2012.00345.", "ArticleIdList": ["10.3389/fphys.2012.00345", "PMC3433738", "22973235"]}, {"Citation": "Gorre F, Vandekerckhove H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta cardiol. 2010;65(5):565\u201372.", "ArticleIdList": ["21125979"]}, {"Citation": "Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004;52:794\u2013804.", "ArticleIdList": ["15909857"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "10", "Day": "2"}, {"Year": "2016", "Month": "12", "Day": "10"}, {"Year": "2016", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2016", "Month": "5", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["27382452", "PMC4930262", "10.19082/2410", "epj-08-2410"]}}], "PubmedBookArticle": []}